Tc-99m PMT hepatobiliary scintigraphy in the differential diagnosis of extrahepatic metastases and hepatocellular carcinoma

Clinical Nuclear Medicine

Volumn 25, Issue 12, 2000, Pages 991-995

  Mochizuki, Teruhito ^a   Tsuda, Takaharu ^a   Sugawara, Yoshifumi ^a   Tanaka, Hiroaki ^a   Kikuchi, Takanori ^a   Miyagawa, Masao ^a   Shimizu, Kenji ^a   Murase, Kenya ^a   Iuchi, Hedehito ^a   Onji, Morikazu ^a   Ikezoe, Junpei ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatobiliary Scintigraphy; Hepatocellular Carcinoma; Metastasis; SPECT

Indexed keywords

DIGLYCINE DERIVATIVE TC 99M; TECHNETIUM 99M; TECHNETIUM N PYRIDOXYL 5 METHYLTRYPTOPHAN TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE METASTASIS; CLINICAL ARTICLE; CONTRAST SENSITIVITY; DIFFERENTIAL DIAGNOSIS; FEMALE; HEPATOBILIARY SCINTISCANNING; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE CHARACTERIZATION;

AGED; BONE NEOPLASMS; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; ORGANOTECHNETIUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M MEDRONATE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRYPTOPHAN;

EID: 0033647414     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200012000-00006     Document Type: Article

References (38)

1. Functional hepatoma demonstrated with rose bengal scanning
2. Uptake of Tc99m-PIPIDA in pulmonary metastases from a hepatoma
3. Clinical significance of Tc-99m-HIDA scintigraphy in liver cell carcinoma and its metastatic foci
4. Hepatocellular carcinoma: Uptake of Tc-99m-IDA in primary tumor and metastasis
5. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent
6. Concentration of Tc-99m-Sn-N-pyridoxyl-5-methyltryptophan, a biliary agent, in distant metastases of hepatomas
7. Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging
8. Comparison of delayed hepatobiliary imaging using Tc-99m-Sn-N-pyridoxyl-5-methyltryptophan and 67Ga-citrate imaging for diagnosis of hepatocellular carcinoma
9. Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: Relationship between detectability and tumor differentiation
10. Comparison of delayed imaging with Tc-99m PMT, Tc-99m DEIDA for visualization of hepatoma
11. Relationship of uptake of technetium-99mSn.-N-pyridoxyl-5-methyltryptophan by hepatocelluar carcinoma to prognosis
12. Analysis of factors affecting uptake of Tc-99m Sn-N-pyridoxyl-5-methyltryptophan by hepatocelluar carcinoma
13. Clinical usefulness of Tc-99m-PMT whole body scans in the diagnosis of bone metastases from hepatocellular carcinoma
14. Metastasis of hepatocelluar carcinoma to the colon demonstrated by Tc-99m PMT scintigraphy
15. Radionuclear estimation with Tc-99m-N-pyridoxyl-5-methyl-tryptophan PMT. Scintigraphy of recurrent hepatocellular carcinoma after non-surgical treatment
16. Isolated porta hepatis metastasis of papillary thyroid cancer
17. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer
18. Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer
19. Bone metastases in pheochromocytoma: Comparative studies of efficacy of imaging
20. Late presentation of metastatic pheochromocytoma: A problem case solved by I-131 MIBG scintigraphy
21. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine MIBG scintigraphy in malignant pheochromocytoma
22. Adrenal masses in oncologic patients: Functional and morphologic evaluation
23. Diagnostic accuracy and pitfalls of [iodine-131] 6-beta-iodomethyl-19-norcholesterol NP-59 imaging
24. 1]-Octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: Synthesis, radiolabelling and in vitro validation
25. Early massive accumulation of In-111 pentetreotide in a metastatic liver tumor of islet cell carcinoma
26. Distinguishing small hepatic hemangiomas from vascular liver metastases in gastrinoma: Use of a somatostatin-receptor scintigraphic agent
27. Neuroendocrine tumors
28. Gastrointestinal tumors
29. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion
30. Hepatocellular carcinoma: Treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection
31. Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: Analysis of prognostic factors
32. Hepatocellular carcinoma: Treatment with percutaneous ethanol injection and transcatheter arterial embolization
33. Small hepatocellular carcinoma: Treatment with subsegmental transcatheter arterial embolization
34. Small hepatocellular carcinoma treated with percutaneous ethanol injection: MR imaging findings
35. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: A European experience
36. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma
37. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer
38. Radio-frequency ablation of hepatic metastases: Postprocedural assessment with a US microbubble contrast agent-early experience